Wordt geladen...
Suppression of B-cell development genes is key to glucocorticoid efficacy in treatment of acute lymphoblastic leukemia
Glucocorticoids (GCs), including dexamethasone (dex), are a central component of combination chemotherapy for childhood B-cell precursor acute lymphoblastic leukemia (B-ALL). GCs work by activating the GC receptor (GR), a ligand-induced transcription factor, which in turn regulates genes that induce...
Bewaard in:
Gepubliceerd in: | Blood |
---|---|
Hoofdauteurs: | , , , , , , , , , , , , |
Formaat: | Artigo |
Taal: | Inglês |
Gepubliceerd in: |
American Society of Hematology
2017
|
Onderwerpen: | |
Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5454339/ https://ncbi.nlm.nih.gov/pubmed/28424165 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2017-02-766204 |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|